Real-time enrollment status for this hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 5:35 PM UTC
| NCT Number | NCT05488522 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | February 20, 2026 (Feb 20, 2026) |
As of August 30, 2026: Clinical trial NCT05488522 is currently recruiting participants. This phase1 study for hepatocellular carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05488522 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05488522 was last updated Feb 20, 2026 (February 20, 2026). HelloStudys verifies this status automatically.